Skip to content
10-K

Annual Report

CASI PHARMACEUTICALS, INC.

0001558370-22-004437

← back to feed
Filed
Mar 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 18, 2022 136.59M sh
Stock Issued FY 2021 · Dec 31, 2021 493K sh
Eps Diluted FY 2021 · Dec 31, 2021 −$0.27
Eps Diluted FY 2021 · Dec 31, 2020 −$0.44
Eps Basic FY 2021 · Dec 31, 2021 −$0.27
Eps Basic FY 2021 · Dec 31, 2020 −$0.44
Gross Profit FY 2021 · Dec 31, 2021 $17.61M
Gross Profit FY 2021 · Dec 31, 2020 $5.63M
Short Term Debt FY 2021 · Dec 31, 2020 $826K
Short Term Investments FY 2021 · Dec 31, 2020 $9.31M
Cash And Equivalents FY 2021 · Dec 31, 2020 $57.06M
Current Liabilities FY 2021 · Dec 31, 2020 $7.98M
Total Liabilities FY 2021 · Dec 31, 2020 $24.16M
Current Assets FY 2021 · Dec 31, 2020 $74.03M
Total Assets FY 2021 · Dec 31, 2020 $127.73M